1 – 11 of 11
- show: 100
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Quality of life among female childhood cancer survivors with and without premature ovarian insufficiency
(
- Contribution to journal › Article
- 2021
-
Mark
Premature ovarian failure after childhood cancer and risk of metabolic syndrome : A cross-sectional analysis
(
- Contribution to journal › Article
- 2019
-
Mark
Anti-müllerian hormone compared with other ovarian markers after childhood cancer treatment
(
- Contribution to journal › Article
- 2017
-
Mark
Congenital malformations in offspring of women with a history of malignancy
(
- Contribution to journal › Article
- 2016
-
Mark
Deliveries after malignant disease before pregnancy : Maternal characteristics, pregnancy, and delivery complications
(
- Contribution to journal › Article
-
Mark
A Biomarker Panel Increases the Diagnostic Performance for Epithelial Ovarian Cancer Type I and II in Young Women
(
- Contribution to journal › Article
- 2015
-
Mark
Age influences the clinical significance of atypical glandular cells on cytology.
(
- Contribution to journal › Article
- 2009
-
Mark
Estradiol attenuates EGF-induced rapid uPAR mobilization and cell migration via the G-protein-coupled receptor 30 in ovarian cancer cells.
(
- Contribution to journal › Article
- 2008
-
Mark
Cleaved forms of the urokinase plasminogen activator receptor in plasma have diagnostic potential and predict postoperative survival in patients with ovarian cancer.
(
- Contribution to journal › Article
- 2006
-
Mark
EGF-stimulated migration in ovarian cancer cells is associated with decreased internalization, increased surface expression, and increased shedding of the urokinase plasminogen activator receptor.
(
- Contribution to journal › Article
- 1998
-
Mark
Nytt behandlingsprogram vid avancerad ovarialcancer. Tillfredsställande resultat med decentraliserad cytostatikaterapi
(
- Contribution to journal › Article